TYPE/SCREEN/PHENOTYPING FOR PRE DARAMUTUMAB THERAPY

Test Code

LAB6651

Alias/See Also

TYPE AND SCREEN FOR DARZALEX
ABORH-DARA

Includes

TYPE and SCREEN
RBC Antigen Phenotypes: C, c, E, e, Fya, Jka, K

Preferred Specimen

6.0ml pink top (EDTA) tube properly labeled with full patient name and phlebotomist identification

Patient Preparation
Red cell transfusions within the last 3 months can provide inaccurate results.

Minimum Volume

3 mL

Other Acceptable Specimens

Lavender top EDTA tube properly labeled with full patient name and phlebotomist identification

Transport Temperature

Refrigerated

Specimen Stability

Refrigerate, stable 72 hours

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)

Hemolysis; lipemia; container damaged and leaking; improperly labeled tube; improperly transported (too hot/frozen); insufficient quantity.

Methodology
Hemagglutination

Setup Schedule

Daily

Report Available

4 hours; 1 Hour STAT

Limitations

Recent transfusions (within 3 months) of red cells may provide inaccurate results.

Clinical Significance

Pre-transfusion testing for patients prior to going on Daramutumab therapy which has been known to interfere with Antibody Screen and Crossmatch interpretations.

Performing Laboratory
CH BLOOD BANK (831-625-1871): CH BLOOD BANK SECTION

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.